✦ LIBER ✦

Δ133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer

✍ Scribed by Hofstetter, G; Berger, A; Schuster, E; Wolf, A; Hager, G; Vergote, I; Cadron, I; Sehouli, J; Braicu, E I; Mahner, S; Speiser, P; Marth, C; Zeimet, A G; Ulmer, H; Zeillinger, R; Concin, N

Book ID: 126968183
Publisher: Nature Publishing Group
Year: 2011
Tongue: English
Weight: 367 KB
Volume: 105
Category: Article
ISSN: 0007-0920
DOI: 10.1038/bjc.2011.433

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Alternative splicing of p53 and p73: the

Alternative splicing of p53 and p73: the novel p53 splice variant p53δ is an independent prognostic marker in ovarian cancer

✍ Hofstetter, G; Berger, A; Fiegl, H; Slade, N; Zorić, A; Holzer, B; Schuster, E; 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 615 KB

p53 immunochemistry is an independent pr

p53 immunochemistry is an independent prognostic marker for outcome in conservatively treated prostate cancer

✍ Sak Kudahetti; Gabrielle Fisher; Laurence Ambroisine; Christopher Foster; Victor 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB

p53 overexpression is Not an independent

p53 overexpression is Not an independent prognostic factor for patients with primary ovarian epithelial cancer

✍ Gamal H. Eltabbakh; Jerome L. Belinson; Alexander W. Kennedy; Charles V. Biscott 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 2 views

ian carcinoma is uncertain. Previous studies have yielded conflicting results and have been hampered by small patient populations, failure to account for other

p53 as an Independent Prognostic Marker

p53 as an Independent Prognostic Marker in Lymph Node-Negative Breast Cancer Patients

✍ Silvestrini, R.; Benini, E.; Daidone, M. G.; Veneroni, S.; Boracchi, P.; Cappell 📂 Article 📅 1993 🏛 Oxford University Press 🌐 English ⚖ 502 KB

p53 Nuclear overexpression may not be an

p53 Nuclear overexpression may not be an independent prognostic marker in early colorectal cancer

✍ Harsh Grewal; José G. Guillem; David S. Klimstra; Alfred M. Cohen 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 893 KB

The p53 positive Bcl-2 negative phenotyp

The p53 positive Bcl-2 negative phenotype is an independent marker of prognosis in breast cancer

✍ Phil Rolland; Ian Spendlove; Zahra Madjid; Emad A. Rakha; Poulam Patel; Ian O. E 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 275 KB

## Abstract The purpose of this work was to determine if the immunohistochemical p53 (+) Bcl‐2 (−) phenotype predicts survival in breast cancer patients. Tissue from 819 cases of resected primary breast cancer, presented between 1986 and 1998, were assembled in tissue microarray format. Clinicopath